United States · FDA National Drug Code directory
Carbamazepine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 75834-221_45806c19-4811-987e-e063-6394a90aa8fa
- Product NDC
- 75834-221
- Form
- TABLET
- Composition / generic term
- Carbamazepine
- Labeler
- NIVAGEN PHARMACEUTICALS, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200421
- Source listing expiry
- 20261231
Source-listed ingredients
- CARBAMAZEPINE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (75834-221-00) · 75834-221-00
- 100 TABLET in 1 BOTTLE (75834-221-01) · 75834-221-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →